One of the in vitro trials discussed the serotonin reuptake transporter (SERT) and IBS relationship [18], and the remaining two in vitro trials displayed how tumor growth factor-beta one and glucagon-like peptide-1 modulate SERT transcription, respectively [23,24]. The gene discussed is SLC6A4; the disease is irritable bowel syndrome.